Logo image of HYPR

HYPERFINE INC (HYPR) Stock Fundamental Analysis

NASDAQ:HYPR - Nasdaq - US44916K1060 - Common Stock - Currency: USD

0.59  -0.03 (-5.19%)

After market: 0.6255 +0.04 (+6.02%)

Fundamental Rating

3

Taking everything into account, HYPR scores 3 out of 10 in our fundamental rating. HYPR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for HYPR as it has an excellent financial health rating, but there are worries on the profitability. HYPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HYPR has reported negative net income.
HYPR had a negative operating cash flow in the past year.
HYPR had negative earnings in each of the past 5 years.
HYPR had a negative operating cash flow in each of the past 5 years.
HYPR Yearly Net Income VS EBIT VS OCF VS FCFHYPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -69.13%, HYPR is doing worse than 75.13% of the companies in the same industry.
HYPR's Return On Equity of -83.03% is in line compared to the rest of the industry. HYPR outperforms 40.21% of its industry peers.
Industry RankSector Rank
ROA -69.13%
ROE -83.03%
ROIC N/A
ROA(3y)-56.89%
ROA(5y)-47.09%
ROE(3y)-64.86%
ROE(5y)-52.85%
ROIC(3y)N/A
ROIC(5y)N/A
HYPR Yearly ROA, ROE, ROICHYPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 45.70%, HYPR is doing worse than 61.90% of the companies in the same industry.
HYPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HYPR Yearly Profit, Operating, Gross MarginsHYPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

7

2. Health

2.1 Basic Checks

HYPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HYPR has been increased compared to 1 year ago.
HYPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HYPR Yearly Shares OutstandingHYPR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
HYPR Yearly Total Debt VS Total AssetsHYPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -5.34, we must say that HYPR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.34, HYPR is doing worse than 70.90% of the companies in the same industry.
HYPR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.34
ROIC/WACCN/A
WACC9.12%
HYPR Yearly LT Debt VS Equity VS FCFHYPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 6.15 indicates that HYPR has no problem at all paying its short term obligations.
HYPR has a Current ratio of 6.15. This is amongst the best in the industry. HYPR outperforms 82.54% of its industry peers.
A Quick Ratio of 5.48 indicates that HYPR has no problem at all paying its short term obligations.
HYPR has a Quick ratio of 5.48. This is amongst the best in the industry. HYPR outperforms 82.54% of its industry peers.
Industry RankSector Rank
Current Ratio 6.15
Quick Ratio 5.48
HYPR Yearly Current Assets VS Current LiabilitesHYPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

HYPR shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.08%.
The Revenue has grown by 16.84% in the past year. This is quite good.
Measured over the past years, HYPR shows a very strong growth in Revenue. The Revenue has been growing by 105.01% on average per year.
EPS 1Y (TTM)5.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)16.84%
Revenue growth 3Y105.01%
Revenue growth 5YN/A
Sales Q2Q%-35.14%

3.2 Future

Based on estimates for the next years, HYPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.04% on average per year.
HYPR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.76% yearly.
EPS Next Y17.13%
EPS Next 2Y12.76%
EPS Next 3Y9.1%
EPS Next 5Y8.04%
Revenue Next Year5.59%
Revenue Next 2Y14.69%
Revenue Next 3Y14.15%
Revenue Next 5Y16.76%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HYPR Yearly Revenue VS EstimatesHYPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5M 10M 15M 20M 25M
HYPR Yearly EPS VS EstimatesHYPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HYPR. In the last year negative earnings were reported.
Also next year HYPR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HYPR Price Earnings VS Forward Price EarningsHYPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HYPR Per share dataHYPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.76%
EPS Next 3Y9.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HYPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HYPERFINE INC

NASDAQ:HYPR (5/21/2025, 5:41:37 PM)

After market: 0.6255 +0.04 (+6.02%)

0.59

-0.03 (-5.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-06 2025-08-06
Inst Owners22.77%
Inst Owner Change-8.57%
Ins Owners4.28%
Ins Owner Change-0.4%
Market Cap45.93M
Analysts78
Price Target1.32 (123.73%)
Short Float %2.36%
Short Ratio1.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.15%
Min EPS beat(2)-1.67%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)2.17%
Min EPS beat(4)-1.67%
Max EPS beat(4)6.42%
EPS beat(8)6
Avg EPS beat(8)2.22%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.91%
Min Revenue beat(2)-24.15%
Max Revenue beat(2)8.33%
Revenue beat(4)3
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-24.15%
Max Revenue beat(4)9.07%
Revenue beat(8)4
Avg Revenue beat(8)-4.32%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)5.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.07%
EPS NY rev (1m)-1.68%
EPS NY rev (3m)7.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.2%
Revenue NY rev (1m)-8.69%
Revenue NY rev (3m)-22.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.56
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0.17
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -69.13%
ROE -83.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.7%
FCFM N/A
ROA(3y)-56.89%
ROA(5y)-47.09%
ROE(3y)-64.86%
ROE(5y)-52.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.96%
Cap/Sales 2.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.15
Quick Ratio 5.48
Altman-Z -5.34
F-Score4
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)57.29%
Cap/Depr(5y)217.57%
Cap/Sales(3y)6.28%
Cap/Sales(5y)146.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y17.13%
EPS Next 2Y12.76%
EPS Next 3Y9.1%
EPS Next 5Y8.04%
Revenue 1Y (TTM)16.84%
Revenue growth 3Y105.01%
Revenue growth 5YN/A
Sales Q2Q%-35.14%
Revenue Next Year5.59%
Revenue Next 2Y14.69%
Revenue Next 3Y14.15%
Revenue Next 5Y16.76%
EBIT growth 1Y10.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.11%
EBIT Next 3Y8.53%
EBIT Next 5YN/A
FCF growth 1Y8.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.28%
OCF growth 3YN/A
OCF growth 5YN/A